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Abstract: At present, there is poor accuracy in assessing cognitive and 
vegetative symptoms in depression using clinician or self-rated measures, 
suggesting the need for development of standardized tasks to assess these 
functions. The current study assessed the psychometric properties and 
diagnostic specificity of a brief neuropsychological screening battery designed 
to assess core signs of depression; psychomotor retardation, attention and 
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executive functioning difficulties, and impaired emotion perception within an 
outpatient psychiatry setting. Three hundred eighty-four patients with mood 
disorders and 77 healthy volunteers participated. A large percentage of 
patients met diagnostic criteria for Major Depressive Disorder alone (49%) or 
with another comorbid psychiatric disorder (24%). A brief, 25-min battery of 
computer-based tests was administered to control participants and patients 
measuring the constructs of inhibitory control, attention, visual perception, 
and both executive and visual processing speed. The patient groups 
performed significantly worse than the control group regardless of diagnosis 
on visual perception and attention accuracy and processing speed factors. 
Surprisingly, the anxiety disorder group performed better than several other 
psychiatric disorder groups in inhibitory control accuracy. Developing valid 
and reliable measures of cognitive signs in mood disorders creates excellent 
opportunities for tracking cognitive status prior to initiation of treatment, and 
allows for reliable retest following treatment. 
Keywords: Depression, Psychiatric disorders, Executive functioning, 
Attention, Affect perception, Cognitive screening, Computers 
1. Introduction 
The burgeoning field of evidence-based medicine is a catalyst 
for the development of objective instruments for diagnosing mental 
disorders and tracking symptoms. Cognitive symptoms in mood 
disorders such as impairments in attention, concentration, inhibitory 
control, psychomotor retardation, affect perception and interpersonal 
sensitivity are amenable to evaluation via these methods. Although 
computer-based cognitive screening has been increasingly employed in 
research (e.g., age-related disorders and head injury), application of 
these computer-based screening measures to psychiatric populations 
and clinical care has been sparse. The present study provides a 
prototype for the use of computer-based cognitive screening measures 
that can be administered and scored with minimal utilization of time 
and financial resources. 
Measurement of specific cognitive deficits in depression and 
related disorders poses specific logistical problems when implemented 
in a clinical setting. For example, large clinical settings often do not 
have technicians (or enough technicians) available to administer 
complex, traditional neuropsychological tests, or the investment of 
resources needed to administer, score, and interpret these tests. 
Computer-based screening batteries, which can be readily translated 
for use in a depression clinic, can provide a meaningful, objective 
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benchmark to aid psychiatrists and other practitioners in deciding 
when a complete neuropsychological evaluation may be needed, or if a 
briefer consultation about the cognitive strengths and weaknesses 
would be of assistance with diagnosis and treatment (Simpson et al., 
1989; Robbins et al., 1994; Letz et al., 1996a,b; Gur et al., 2001a,b; 
Feiger et al., 2003). Many of the previously developed computer-based 
batteries used with other populations provide normative data from a 
large cohort of individuals, yet none have been specifically designed or 
validated for use with depressed patients. For example, batteries 
designed for older individuals use paradigms that are often far too 
easy, and thus insensitive, to difficulties specific to depression 
(Sweeney et al., 2000). In fact, a large number of these paradigms 
are used to distinguish between demented elderly and depressed 
elderly, with the goal of demonstrating no difficulties in the depressed 
elderly, clearly not the ideal parameters for use in psychiatric settings. 
Tasks designed for use in a depression clinic must possess adequate 
clinical relevance and psychometric accuracy, must be sensitive to 
weaknesses reported by patients, and must minimize the 
methodological challenges evident in prior research with tasks 
developed for use with other populations. 
Some existing research suggests a continuum of cognitive 
dysfunction in depression and related mood disorders that closely 
matches the perceived disease severity, and perhaps the long-term 
prognosis of these disorders. For example, attention and executive 
functioning deficits noted in bipolar disorder are often more severe 
than those observed in unipolar depression (Sweeney et al., 2000; 
Borkowska and Rybakowski, 2001). Furthermore, people with anxiety 
disorders rarely display any measurable cognitive difficulties, often 
outperforming those with other mood disorders and performing 
similarly to healthy controls (Gilboa-Schechtman et al., 2002). Some, 
however, have failed to demonstrate a distinction between mood 
disorders in cognitive functioning, suggesting that there are only small 
to modest effect sizes (Hoff et al., 1990; Franke et al., 1993). 
Therefore, studies with fewer participants may be underpowered to 
detect these differences. Length of illness, genetic predisposition, and 
medications may also affect performance on cognitive tests for those 
with various mood disorders (Kessing, 1998; Naismith et al., 2003; 
Martinez-Aran et al., 2004). Nonetheless, it is reasonable to 
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hypothesize that individuals with varying mood disorders may differ by 
both the extent and pattern of cognitive difficulty. 
The current study presents the psychometric properties and 
diagnostic specificity of a brief neuropsychological screening battery 
designed to assess core signs of depression; psychomotor retardation, 
attention and executive functioning difficulties, and impaired emotion 
perception. It was expected that valid, reliable performance could be 
obtained on these tests, with factors matching core cognitive 
constructs of attention accuracy, inhibitory accuracy, emotion 
processing accuracy, and psychomotor speed, and that each derived 
factor would demonstrate strong internal reliability. Relationships 
between performance and symptoms, length of illness, and diagnostic 
subtype were also explored. 
2. Methods 
2.1. Participants 
Consecutive patients (clinic patients, n = 332) arriving for their 
first psychiatric appointment with a University of Michigan Depression 
Center treatment team were included in the study. Additional research 
participants, both control and depressed, were recruited through 
projects at the University of Michigan volunteers responding to flyers 
posted at the Medical Center (mood disorder patients n = 52, Control 
n = 43) and Marquette University college undergraduates receiving 
course credit (Control n = 34). As described in detail below, four 
control participants and 17 patients did not perform with valid 
cognitive data leaving a total of 73 participants in the control group 
and 367 participants in the patient group. Only patients and controls 
who demonstrated valid data were included in all statistical analyses. 
The Institutional Review Boards (IRB) at each respective institution 
approved the corresponding study protocol. After complete description 
of the study to the participants, written informed consent was obtained 
from research participants. Clinic data from patients was deidentified 
with an IRB approved waiver of informed consent for this data. The 
diagnostic breakdown and demographic characteristics for the 
participants are provided in Table 1. 
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Table 1. Demographic information for diagnostic groups 
Diagnosis code N/N 
valid 
% 
Female 
% Taking 
medications 
Age Education 
M (S.D.) M (S.D.) 
Major depression 
(MDD) 
188/179 73.9 60.6 35.5 (12.1) 15.4 (2.8) 
MDD and anxiety 62/59 63.0 70.0 35.8 (10.8) 15.5 (2.6) 
MDD and dysthymia 29/27 65.6 48.3 35.5 (11.1) 16.2 (2.9) 
Dysthymiaa 6/6 83.3 66.7 42.2 (13.8) 16.5 (1.8) 
Bipolar 25/24 60.0 96.0 35.8 (9.6) 15.7 (2.8) 
Mood disorder NOSa 12/11 50.0 50.0 35.6 (14.4) 15.1 (3.6) 
Adjustmenta 12/12 83.3 58.3 35.1 (12.5) 15.9 (1.8) 
Generalized 
anxietyb 
19/19 57.9 79.0 36.4 (13.2) 15.0 (3.3) 
Obsessive 
compulsiveb 
5/5 40.0 80.0 36.2 (9.1) 15.6 (1.7) 
Panicb 7/7 85.7 62.5 33.1 (10.6) 13.0 (1.9) 
Social phobiab 3/3 0.0 66.7 39.3 (19.6) 14.7 (3.1) 
Nonea 16/15 68.8 31.3 29.3 (6.8) 14.6 (3.1) 
Control 77/73 57.1 0.0 25.1 (9.2) 14.5 (2.5) 
Total 461⁎/440 66.1 62.5 33.7 (11.9) 15.3 (2.7) 
aIncluded for psychometric analyses, excluded from group analyses due to small 
sample size. 
bCombined into Anxiety disorder group. 
*21 participants data excluded due to performance 2.5 standard deviations below each 
group mean on two easy tasks (e.g., Level 1 percent correct targets for the Parametric 
Go/No-go task and percent correct animal categorization for the Facial Emotion 
Perception Test). 
Control participants were screened for depression using the 
Hamilton Rating Scale for Depression (HRSD, < 5, Hamilton, 1960, 
1967), Beck Depression Inventory-II (BDI, < 6, Beck et al., 1988), 
and/or clinical interview. All mood disorder patients were diagnosed 
using DSM-IV criteria by board-certified psychiatrists (n = 362) or 
using the Structured Clinical Interview for DSM-IV (n = 22, First et al., 
1995). Depression symptoms in clinic patients were assessed with the 
Personal Health Questionnaire (Kroenke et al., 2001). Current or past 
history of psychological or neurological problems in self or first degree 
relatives was ground for exclusion of control participants. Patients 
were excluded if there was a current or past diagnosis of psychosis or 
neurological disorder, a severe medical disorder that might be 
reasonably be expected to impact cognitive functioning (e.g., 
myocardial infarction), or current alcohol or substance 
abuse/dependence. 
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2.2. Materials 
2.2.1. Synonym Knowledge task 
The Synonym Knowledge task (SKT; based on Shipley, 1946) 
was used as an estimate of verbal intelligence. It was expected that 
this would serve as a control task, with no differences between the 
groups. Participants were presented with a word and then asked to 
choose which of four additional words was most similar in meaning to 
the word first presented. There was no penalty for guessing and no 
time limit for responding. 
2.2.2. Facial Emotion Perception task 
The Facial Emotion Perception task (FEPT; Rapport et al., 2002; 
Langenecker et al., 2005) was used to assess accuracy and speed of 
recognition of facial expressions (e.g., impaired emotion perception) 
and animal categorization. The FEPT was used to assess emotion 
perception and processing, a domain of decreased functioning in 
depression and other mood disorders research (Gur et al., 1992; 
Mayberg et al., 1999; LeDoux, 2000). Participants were presented with 
and asked to rapidly categorize faces (from Ekman and Friesen, 1976) 
and animals. For the face trials, participants categorized the facial 
expression into one of four possibilities: happy, sad, angry, or fearful. 
For the animal trials, participants categorized the animal into one of 
four possibilities: dog, cat, primate, or bird. A stimulus is presented for 
300 ms, followed by a mask for 100 ms, and then 2600 ms are 
provided as a response window. Trials are separated by the 
presentation of a cross for 500 ms. 
2.2.3. Parametric Go/No-go task 
The Parametric Go/No-go (PGNG) task (Langenecker et al., 
2005, based upon Garavan et al., 1999; Nielson et al., 2002; 
Langenecker and Nielson, 2003) was used to assess inhibitory control, 
attention and problem-solving abilities (e.g., attention and executive 
functioning, see Fig. 1) and associated brain areas also strongly 
implicated in depression research (Austin et al., 1999; Bush et al., 
2000; Pizzigalli et al., 2001). The PGNG consist of a rapid 
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(interstimulus interval = 500 ms) serial presentation of alphabet 
letters, where targets are “x”, “y”, or “z”. In the Go condition (Level 
1), the participant is instructed to respond to any of the targets, 
regardless of the order of presentation. In the Two-target Go/No-go 
condition (Level 2), the participant responds the targets “x” and “y”, 
but only in alternation (non-repeating rule, see Fig. 1). The Three 
Target Go/No-go task (Level 3) includes all three targets, with the 
same non-repeating rule. As such, the working memory load for each 
inhibitory condition was minimal (2, 3 targets), while updating of the 
to-be-inhibited-target was important, as was control of impulsive 
responding to repeating targets. Therefore, two aspects of inhibitory 
control are measured (Hasher and Zacks, 1988); behavioral response 
inhibition (e.g., impulsivity), and removal inhibition (e.g., updating 
working memory rules or set-shifting). Finally, the PGNG provide for 
an assessment of psychomotor retardation, with three levels of 
cognitive load. 
 
Fig. 1. The Go/No-go task illustration. The non-repeating rule is illustrated for Level 2 
and Level 3 Go/No-go, while the Level 1, Go task requires responses to all target 
stimuli regardless of order. 
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2.3. Procedure 
After greeting the participant, an assistant explained that the 
project was designed to measure verbal ability, emotion perception, 
attention, and inhibition skills. The participant was assured that the 
task was not designed for perfect performance, nor was the screen 
designed as a thorough measure of cognitive functioning. Once the 
participant understood the procedure, the assistant then administered 
the three computer-based tasks. 
2.4. Statistical analyses 
Outliers in the data were truncated using a winsor procedure as 
outlined elsewhere (Tabachnik and Fidell, 2001). Descriptive statistics 
for the dependent variables were computed, including standard error 
of measurement. Groups were compared on demographic factors and 
appropriate corrections were made. A chi-square was computed to 
determine whether there were a disproportionate number of outlier 
data points for patients (n = 367) versus control (n = 73) participants. 
A principal axis factor analysis (Control n = 73, Patient n = 367) with 
oblique rotation was computed with the executive and emotion 
processing dependent variables. Odd-even item reliability (with 
Spearman–Brown coefficients) was computed for each of the derived 
factors (Control n = 73, Patient n = 367). The relationship between 
illness, demographic characteristics and cognitive factors was also 
explored. A MANOVA was used to address hypothesized differences on 
the cognitive factors between the age-matched control (n = 42) and 
mood disorder (n = 367) groups. 
3. Results 
3.1. Demographic characteristics 
The control group did not differ from the patient groups on 
education (F = 1.10, df = 12,395, P = 0.31, E2 = 0.032); or estimated 
IQ (from SKT, F = 1.16, df = 12,373, P = 0.31, E2 = 0.036). There 
were significant differences for age (F = 5.14, df = 12,448, 
P < 0.0001, E2 = 0.121); the control group was significantly younger 
than the patient groups (all P's < 0.04). There were also more males 
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in the control group compared to the entire mood disorder sample 
(X¯ = 3.71, n = 461, P = 0.05), although several patient groups had 
nearly identical male/female ratios as the control group. The age and 
gender differences were controlled for by age-matching groups of 
mood disorder and control participants, and by removing a 
disproportionate percentage of young males from the sample (e.g., 
18- and 19-year-old males, although some females from this age 
range were also removed). As a result, there were no differences 
between the age/gender-matched control group and the patient 
groups on age (control M = 29.5, S.D. = 9.8, F = 1.48, df = 12,395, 
P = 0.13, E2 = 0.043) or gender distribution (73.8% female, 
X¯ = 0.53, n = 461, P = 0.46). 
3.2. Descriptive statistics and measures of performance 
validity 
Descriptive statistics are presented for each dependent variable 
in Tables 1 and 2. In general, simpler tasks tended to be more 
skewed. Validity of performance was determined using outlier criteria 
for each group (control, psychiatric separately), a combination of 
ascertaining deviance from the mean (e.g., 2.5 S.D.) and taking into 
consideration the distribution of scores (e.g., boxplot determination) 
on two easy tasks (Level 1 percent correct targets for the PGNG task 
and percent correct animal categorization for the Facial Emotion 
Perception Test). A chi-square comparing the number of out of range 
(e.g., invalid performance) variables between patient (n = 367) and 
control (n = 73) groups was not significant (X¯ = 3.47, n = 461, 
P = 0.99). The number of valid cases for each group, based upon 
psychometric deviance and performance probability on the cognitive 
tasks, is presented in Table 1. All participants with valid performance 
(n = 440) were used to assess the psychometric properties of the 
tasks and relationships with clinical variables (Sections 3.3–3.5), while 
only matched control and patient groups with more than 20 subjects 
were used to determine any subgroup differences (Section 3.6). Only 
the control group matched by age and gender to the patient groups 
was used to test this assumption, as age, and possibly gender, could 
have a significant impact on performance. 
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Table 2. Psychometric statistics for dependent variablesa 
Descriptive statistics M (S.D.) Min. Max. Skewness Kurtosis 
Facial emotion perception task, N = 440 
Accuracy 
     
 % Correct Animals 92.2 (10.7) 58.0⁎ 100.0 − 1.5 1.7 
 % Correct faces 83.5 (10.7) 44.0⁎ 100.0 − 1.5 2.5 
Response time 
 Animals RT 969.7 (335.1) 402.5⁎ 1846.0⁎ 0.8 0.1 
 Faces RT 1067.2 (307.3) 422.3 1832.0⁎ 0.7 0.1 
 Neutral faces RT 1372.8 (454.4) 383.0⁎ 2475.0⁎ 0.3 − 0.1 
Ambiguous stimuli 
     
 % Rated negatively 80.8 (25.9) 0.0 100.0 − 1.4 1.1  
Parametric Go/No-go Task, N = 440 
Attention accuracy 
 Level 1 96.7 (4.6) 81.9⁎ 100.0 − 1.8 2.8 
Attention, inhibition/updating working memory. Set-shifting, accuracy 
 Level 2 92.7 (10.3) 61.0⁎ 100.0 − 1.8 2.6 
 Level 3 83.0 (12.6) 46.0⁎ 98.1 − 1.0 0.2 
Inhibitory control accuracy 
 Level 2 79.2 (18.4) 25.0⁎ 100.0 − 1.1 0.8 
 Level 3 69.4 (18.8) 23.0⁎ 100.0 − 0.4 − 0.4 
Response time 
     
 Level 1 461.6 (50.7) 360.3 602.0⁎ 0.8 0.5 
 Level 2 462.7 (67.3) 335.9 649.0⁎ 1.0 0.8 
 Level 3 530.1 (73.2) 354.3 750.0⁎ 0.7 0.5 
Synonym knowledge, N = 383 
 % Correct 70.5 (13.5) 8.0 95.0 − 1.2 2.5 
RT = response time; S.D. = standard deviation; Level 1 = Three-target level of the 
Parametric Go/No-go test; Level 2 = two-target level of the Parametric Go/No-go test; 
Level 3 = three-target level of the Parametric Go/No-go test. 
aValid performance data only. 
*Outlier/winsor threshold. 
3.3. Factor analysis and reliability 
A principal axis factor analysis (control n = 73 and patient 
n = 367) with oblique rotation was computed to determine whether 
there were separate constructs for emotion processing and executive 
functioning. As can be seen in Table 3, a five-factor solution was 
extracted. Three of these factors were entirely comprised of the PGNG 
variables and the remaining two included facial emotion perception 
variables (Table 3). The two processing speed factors (r = 0.42, 
P < 0.001) were moderately correlated. As can be seen from the 
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correlation matrix included in Table 4, there was little shared variance 
in accuracy factors for the Go/No-go and FEPT tasks. Eigenvalues, 
variance for each factor (total = 68%), odd–even item reliability and 
Spearman–Brown coefficients are included in Table 4. Spearman–
Brown coefficients for four of the five factors (Visual–Perceptual 
Processing Speed, Inhibitory Processing Speed, Attention and Set 
Shifting Accuracy, Visual–Perceptual Accuracy) ranged from 0.87 to 
0.95, with the Inhibitory Accuracy factor coefficient at 0.67. Thus, the 
factors match accepted constructs and have good to excellent 
reliability. 
Table 3. Factor structure for the parametric Go/No-go task and the facial 
emotion perception taska  
1. 2. 3. 4. 5. 
Accuracy (% correct-
PC) 
     
 PC Animals 
    
0.63 
(− 0.66) 
 PC Faces 
    
0.65 
(− 0.75) 
 Level 1 PC Targets 
  
0.39 
(0.43) 
  
 Level 2 PC Targets 
  
0.39 
(0.47) 
  
 Level 2 PC Inhibitions 
   
0.48 
(0.50) 
 
 Level 3 PC Targets 
  
0.81 
(0.80) 
  
 Level 3 PC Inhibitions 
   
0.59 
(0.56) 
 
Neutral stimuli 
     
 % Ranked negatively 
     
Response time (RT) 
     
 Animals RT 0.74 
(0.82) 
    
 Faces RT 0.94 
(1.00) 
    
 Neutral Faces RT 0.65 
(0.59) 
    
 Level 1 RT 
 
0.63 
(0.67) 
   
 Level 2 RT 
 
0.84 
(0.87) 
   
 Level 3 RT 
 
0.96 
(0.90) 
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Principal Axis Factoring. Oblimin Rotation. 1. Visual–Perceptual Processing Speed, 2. 
Inhibitory Processing Speed, 3. Attention Accuracy, 4. Inhibitory Accuracy, 5. Visual–
Perceptual Accuracy. Level 1 = three target Go, Level 2 = two target Go/No-go, Level 
3 = three target Go/No-go. Values are factor loadings from the pattern matrix, with 
values less than 0.30 are omitted for ease in reading the table. N = 440. 
aFactor structure is identical for two (factors 1 and 2 for response time) and three 
(factors 3 through 5 for accuracy variables) factor solutions if response time and 
accuracy variables are entered separately. Loadings from the two separate factor 
analyses are included in parentheses for comparison. 
Table 4. Factor correlation matrix, eigenvalues, % variance, and reliability 
statistics 
Factor 1. 2. 3. 4. 5. 
1. Visual–perceptual processing speed – 0.42⁎⁎ 0.32⁎⁎ 0.11⁎ 0.43⁎⁎ 
2. Inhibitory processing speed 
 
– 0.38⁎⁎ 0.01 0.31⁎⁎ 
3. Attention accuracy 
  
– 0.15⁎⁎ 0.43⁎⁎ 
4. Inhibitory control accuracy 
   
– 0.13⁎⁎ 
5. Visual–perceptual accuracy 
    
–  
Factor statistics 
Eigenvalues 4.3 1.7 1.4 1.2 1.0 
% Variance 30.7 11.8 9.7 8.9 6.9 
Reliability 
     
Spearman–Brown 0.95 0.95 0.94 0.67 0.87 
Odd–even r 0.91 0.91 0.88 0.50 0.78 
*P < 0.005, ⁎⁎P < 0.0001, N = 440. Odd–even correlations are for odd and even 
items from the FEPT and PGNG tasks. % Variance lists the unique variance for each of 
the factors derived from the principal axis factor analysis. Spearman–Brown correction 
is a correction for split-half reliability, controlling for loss of half of the items in the 
scale through odd–even split reliability. 
3.4. Clinical characteristics 
Both patient groups (i.e., clinic and volunteer patients) had 
moderate symptoms of depression (clinic patients n = 317, PHQ-9 
M = 13.5, S.D. = 6.3, patient volunteers n = 39, HRSD-17 M = 15.5 
and S.D. = 6.2, BDI-II M = 21.3, S.D. = 10.8). When comparing clinic 
patients and volunteers with psychiatric illness, the only difference 
between the two groups, of all demographic and cognitive variables, 
was on the Attention and Set-Shifting Accuracy factor (see below), on 
which clinic patients performed significantly worse than the patient 
volunteers (F = 5.6, df = 1,401, P = 0.018, E2 = 0.014]. The average 
age of onset was 23 years (S.D. = 11.4), with mean symptom 
duration of 12.3 years (S.D. = 11.5). Increasing depression symptoms 
(BDI-II, HRSD, PHQ-9) were associated with decreased attention and 
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set shifting accuracy (BDI-II n = 69, r = − 0.30, P = 0.013, HRSD 
n = 72, r = − 0.26, P = 0.026, but not PHQ-9 n = 271, r = − 0.12, 
P = 0.053), slower visual processing speed (BDI-II n = 69, r = − 0.28, 
P = 0.021, HRSD n = 72, r = − 0.29, P = 0.014, PHQ-9 n = 271, 
r = − 0.05, P = 0.384), decreased inhibitory control (PHQ-9 only 
n = 271, r = − 0.14, P = 0.027) and slower inhibitory processing 
speed (PHQ-9 only n = 271, r = − 0.17, P = 0.005). Age of onset and 
years of illness (n = 283 for all correlations) were significantly 
correlated with visual spatial accuracy (r = − 0.22, P = 0.0001 and 
r = − 0.15, P = 0.014, respectively), visual spatial processing speed 
(r = 0.27, P = 0.0001 and r = 0.18, P = 0.002, respectively), and 
inhibitory processing speed (r = 0.12, P = 0.038 and r = 0.26, 
P = 0.0001, respectively), while attention accuracy was significantly 
negatively correlated with years of illness only (r = − 0.04, P = 0.52 
and r = − 0.22, P = 0.0001, respectively). No correlations between 
symptoms, clinical characteristics and cognitive performance levels 
remained significant when age and education were covaried. All factors 
except Inhibitory Accuracy (r = 0.00, P = 0.99) were significantly 
correlated with age (r's < − 0.24, P's < 0.0001) and all factors except 
inhibitory processing speed (r = 0.02, P = 0.68) were significantly 
correlated with education (all r's > 0.11, P's < 0.03). 
3.5. Medication effects 
Differences in psychotropic medication status are noted between 
the patient diagnostic groups listed in Table 1 (X¯ = 25.7, n = 384, 
P < 0.007). Several groups (Bipolar Disorder 97%, Generalized 
Anxiety Disorder 79%, Obsessive Compulsive Disorder 80%, and 
Comorbid Depression and Anxiety 66%) were more likely to be taking 
psychotropic medications at intake when compared to other groups 
(None, 31%, Mood Disorder NOS 50%, Comorbid Depression and 
Dysthymia, 48%). Medication-free volunteers were recruited 
specifically for one of the research studies. As such, it was expected 
that the patient volunteers (54%) would be more likely to be 
medication free compared to the clinic patients (36%, X¯ = 6.2, 
n = 367, P = 0.01). Medications taken were from 10 different classes 
(1. benzodiazepines and similar, 2. opiates, 3. non-opiate pain 
medications, 4. stimulants, 5. selective 5HT1 and 5HT2 agents, 6. 
selective serotonin and neuroepinephrine re-uptake inhibitors, 7. 
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tricyclics, 8. lithium, 9. mood stabilizers, and 10. atypical 
antipsychotics). Those patients currently taking medications performed 
more poorly only on the Inhibitory Accuracy Factor (t = 2.09, 
df = 364, P < 0.04). No differences were found for the other factors 
(all t's < 1.5 and P's > 0.15). Future studies with larger sample sizes 
are needed to address any cognitive side-effects of medication type as 
the current study was underpowered to do so (many patients were 
taking multiple medications, confounded by severity and type of 
illness—non-random prescriptions). 
3.6. Performance differences between mood disorder 
and control groups 
It was expected that performance differences would exist 
between the control (n = 42) group and the diagnostic subgroups 
(n = 323). It was also expected that cognitive dysfunction would be 
greater in those diagnostic subgroups with more severe mood 
disorders (e.g., dual diagnosis, bipolar disorder) as a marker of 
psychiatric severity compared to less severe mood disorders. A 
MANOVA was computed with diagnostic code as the independent 
variable and performance in the respective cognitive factors as 
dependent variables. Due to small numbers and lack of differences in 
cognitive performance between the anxiety disorder groups (Social 
Phobia, Generalized Anxiety, Panic Disorder, and Obsessive 
Compulsive Disorder, all F's < 1.34, P's > 0.28), they were combined. 
When comparing all the mood groups (MDD, Anxiety, Bipolar, 
comorbid MDD/Dysthymia, comorbid MDD/Anxiety) to each other and 
to the matched control group, the main effect for cognitive 
performance was significant (F = 1.57, P = 0.04, E2 = 0.021). Post hoc 
analyses (Fig. 2) indicated that the matched control group performed 
better than several patient groups (MDD, P = 0.007, Anxiety 
P = 0.052, comorbid MDD/Dysthymia, P = 0.037, and comorbid 
MDD/Anxiety, P = 0.026) on Visual–Perception Accuracy and Visual–
Perceptual Processing Speed (MDD, P = 0.027, Bipolar Disorder, 
P = 0.016, and comorbid MDD/Anxiety, P = 0.033). For Inhibitory 
Control Accuracy, the Anxiety Disorders group performed better than 
the Bipolar (P = 0.017) and MDD/Dysthymia (P = 0.028) groups. The 
matched control group performed better than all patient groups (all 
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P's < 0.003) on Attention and Set-Shifting Accuracy. The cognitive 
tests and derived factors selected for this screening battery are 
sensitive to attention, executive functioning, emotion processing, and 
psychomotor functioning in mood disorders. 
 
Fig. 2. Factor scores for cognitive factors comparing psychiatric subgroups, matched 
to control participants. P values are included in parentheses. aThe matched control 
group performed better than all patient groups (all P's < 0.003) on the Attention and 
Set-Shifting Accuracy factor. bFor the Inhibitory Control Accuracy factor, the Anxiety 
Disorders group performed better than the MDD (P = 0.069), Bipolar (P = 0.017), and 
MDD/Dysthymia (P = 0.028) groups. cThe comorbid MDD/Anxiety group performed 
marginally better than the Bipolar group (P = .088) on the Inhibitory Control factor. 
dThe matched control group performed better than all patient groups except the 
Bipolar group on the Visual Perception Accuracy Factor (MDD, P = 0.007, Anxiety 
P = 0.052, MDD/Dysthymia, P = 0.037, and MDD/Anxiety, P = 0.026). eThe matched 
control group performed marginally faster than the MDD (P = 0.077) and the Bipolar 
(P = 0.079) groups on the Inhibitory Processing Speed factor. fThe matched control 
group also outperformed several patient groups on the Visual–Perceptual Processing 
Speed factor (MDD, P = 0.027, Bipolar Disorder, P = 0.016, MDD/Anxiety, P = 0.033). 
In order to better test the hypothesis that emotion processing is 
impaired in mood disorders, the two variables that comprise the 
Visual–Perception Accuracy factor were analyzed in a second posthoc 
MANOVA. This MANOVA compared the matched control and different 
diagnostic groups with the scores on face emotion and animal 
perception as the dependent variables. The control group performed 
better than the MDD (P = 0.014, P = 0.033) and comorbid 
MDD/dysthymia (P = 0.062, P = 0.088) groups in facial emotion 
perception and animal categorization variables, respectively, and 
better than the Anxiety (P = 0.026) and comorbid MDD/Anxiety 
(P = 0.021) groups in animal categorization. 
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4. Discussion 
This study demonstrated that, using the present computer-
based screening battery, reliable and objective information can be 
gathered with fairly minimal investment of time and resources. The 
battery was designed specifically for use with a psychiatric population 
in an outpatient setting. Therefore, in the future, the battery might be 
used as a screening tool in primary psychiatry and family medicine 
clinics to indicate who may benefit from a more comprehensive 
evaluation. The battery might also be used to determine when 
consultations with a neuropsychologist may be beneficial to interpret 
poor performance and to assist in managing cognitive weaknesses. 
Evaluation of the validity of performance was important, as 
concerns about quantifying valid versus invalid data are particularly 
salient when employing computer-based cognitive testing (Gur et al., 
2001a,b). Over 95% of participants performed within the valid range 
on the FEPT and Go/No-go tasks, supporting the hypothesis that valid 
data could be generated using the computer-based battery. As another 
mechanism for assessing validity of performance, performance on a 
synonym knowledge task was included in the battery (Cohen et al., 
1982; Ellis et al., 1989). As anticipated, the patient and control groups 
did not differ on this measure. Similar performance levels on the 
synonym knowledge task across groups suggest that effort was 
equivalent for these groups as well. This finding is particularly 
important given the known performance challenges in depression 
(e.g., poor motivation, Rohling et al., 2002). These findings also 
suggest that visual motor ability was not the main reason for 
differences between groups on the cognitive factors of interest. 
A factor analysis was also conducted to determine the nature 
and soundness of the psychometric properties of the tasks. It was 
expected that the factors would map onto known cognitive constructs 
and demonstrate good reliability. From the results, it was clear that 
the two primary tasks (Go/No-go and FEPT) were largely independent 
of each other in terms of the cognitive substrates underlying 
performance. Each of the factors demonstrated moderate to strong 
reliability. The relationship between the visual–perceptual accuracy 
and attention and set-shifting accuracy factors was modest. Likewise, 
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the relationship between response time factors for the Parametric 
Go/No-go and Facial Emotion Perception tasks were also modest. 
Inverse relationships between response time and accuracy factors for 
each of these tasks was in line with standard response time/accuracy 
trade-offs (Gur et al., 2001b). Inhibitory accuracy was a highly 
independent factor, suggesting that it is not synonymous with 
attention or set-shifting skills. Although not within the purview of the 
present study, the lack of a significant relationship between the 
attention/set-shifting factor and the inhibitory control factor supports 
the contention that there are separate executive functions as opposed 
to one executive function multiprocessor. In addition, the separation of 
attention and inhibitory factors as separate constructs is consistent 
with our prior work (Miller et al., 2004). 
It was also expected that cognitive dysfunction would exist 
along a continuum from no impairment in the control group, mild 
dysfunction in the less severe diagnostic subgroups, and more 
significant cognitive impairment in persons with more severe 
disorders. This hypothesis was not supported as there were cognitive 
difficulties in almost all of the patient groups. The executive 
functioning and emotion processing difficulties found in MDD, disorders 
comorbid with MDD, and Bipolar disorder are consistent with prior 
work (Gur et al., 1992, 2001a; Lemelin et al., 1996; Langenecker et 
al., 2005). However, closer inspection of Fig. 2 shows that the Bipolar 
group was slower and less accurate on the PGNG compared to the 
other groups. 
One striking result from the present study was the difference in 
performance of the anxiety disorders group on inhibitory control 
accuracy, on which they outperformed all other groups. Careful 
inspection of performance on the attention and inhibitory control 
factors suggests that the anxiety disorders group may have been 
willing to sacrifice errors of omission to avoid errors of commission, 
consistent with prior reports of hypervigilance in this group (Nutt, 
2001). This suggests that response profiles may be useful in 
distinguishing between persons with primary anxiety and mood 
disorders. 
Illness and demographic factors were also found to be 
associated with cognitive functioning. Most notably, increasing 
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symptom severity, age, age of onset, and years of illness were 
significantly negatively related to performance on the attention and 
set-shifting accuracy factor, consistent with prior cross sectional 
results. Slowed processing speed on the FEPT and PGNG were related 
with increasing symptom severity and age, but not age of onset or 
years of illness. If age is entered as a covariate in partial correlations, 
none remained significant, particularly as age of onset and years of 
illness are positively related to current age. Studies with larger 
samples are needed to better assess age and age of onset confounds 
through patient-to-patient matching. 
Despite strong interest over the past two decades, findings of 
attention and executive functioning difficulties in depression and 
related disorders have not been consistently reported (Lemelin et al., 
1996; Schatzberg et al., 2000; Williams et al., 2000; Gotlib et al., 
2004; Langenecker et al., 2005). The present study demonstrates that 
on measures of sustained attention and set-shifting, a number of 
patient groups performed significantly poorer than the control group. A 
recent study has reported decreased behavioral activation in 
depressed patients, which might be analogous to the decreased 
performance on the attention and set-shifting factor, or target 
responses (Kasch et al., 2002). Contrary to expectation, there was 
little evidence of difficulties with impulse control in the patient groups 
in the present study. Kasch et al. (2002) reported similar findings of 
increased behavioral inhibition in patients with depression, which 
would likely result in increased inhibitory control performance. 
Depression and related disorders have long been viewed as 
absent of cognitive impairment and have been traditionally referred to 
as “functional” disorders. However, a number of studies, including the 
present results, suggest that this view is premature (Hale, 1998; 
Dunkin et al., 2000). Many of the measures used in the past as an aid 
in screening for dementia were specifically designed to elicit intact 
performance in those with mood disorders. Not surprisingly, a number 
of these instruments are relatively insensitive to deficits in executive 
functioning, attention and emotion perception difficulties in depression 
and related groups (Gold et al., 1999; Hobart et al., 1999; Gur et al., 
2001a; Dickerson et al., 2004; Boustani et al., 2005). Furthermore, 
many of the previously designed computer-screening measures do not 
measure emotion perception and processing, which are rapidly 
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emerging as key components of mood disorders and have, along with 
executive functioning tasks, been shown to predict treatment response 
(Hale, 1998; Dunkin et al., 2000; Kampf-Sherf et al., 2004). 
One limitation of the current study was the age difference 
between the control group and the patient groups. However, this issue 
was addressed by removing a number of the younger control 
participants from the analysis and then comparing age-matched 
control and patient groups on the cognitive tests. One possible age-
related explanation for the present findings is thus removed by age-
matching. For example, if unmatched for age, there is the potential for 
an interaction between age and psychiatric status to confound the 
results of cognitive performance. For example, declines in visual acuity 
and visual perceptual abilities are reported with age in older samples 
than the current sample (Fisk and Rogers, 1991; Madden et al., 2004; 
Cabeza et al., 2004). As there were only 25 participants over the age 
of 55, a very conservative threshold for the onset of significant age-
related cognitive decline, there is little to no possibility that age is a 
relevant factor in the present results. Some might also consider the 
lack of a verbal memory measure in the current study a limitation. The 
focus of the current screening measures was on cores signs of 
depression, including psychomotor retardation, attention and 
executive functioning difficulties, and impaired emotion perception, 
rather than verbal memory. However, for additional utility, future 
studies might add it into the screening battery. 
Another limitation of the present sample is that the patients 
were largely selected from a tertiary care clinic and may be more 
severe than those seen in regular clinical settings. The average length 
of illness for this group was 13 years, which may truly represent a 
more chronic, severe sample. Finally, brief batteries such as the one 
used in the present sample do not allow for a traditional, more 
thorough assessment of multiple cognitive domains. We acknowledge 
the tension between speed and breadth, and note that a screening 
battery should be sensitive, which appears to be the case here, and 
necessarily sacrifices breadth and depth for speed. As a large 
percentage of the mood disorders patients exhibited difficulty with 
these screening measures, it is likely that few with significant cognitive 
difficulties would be missed by such a screen, which is an important 
consideration, if beyond the purview of the present study. 
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In summary, the present study provides a foundation for future 
studies regarding the application of computer-based tasks of cognitive 
functioning to mood disorder populations. Computerized tasks can be 
administered by technicians and can yield valid data from the vast 
majority of participants within clinical and research settings. When 
poor performance is evident, the screening data can be sent to a 
consulting neuropsychologist to determine if a more thorough 
evaluation would be of benefit. Use of a battery of this type effectively 
addresses many practical limitations to collecting cognitive screening 
data in primary care clinics. Moreover, the present tasks have sound 
psychometric properties, including a factor structure that maps onto 
both theoretical premises and empirical findings reported in previous 
literature. In addition, these tasks demonstrated validity and are 
sensitive to attention, executive functioning, and emotion perception 
difficulties that were evident in the patient groups. It is possible that 
the tasks described in this paper will provide further insight into the 
functioning of brain systems known to be affected in mood disorders. 
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